BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
Sebastian Schwind, Clara D. Bloomfield(North Shore University Hospital), Kelsi B. Holland(University of Iowa), Heiko Becker(University of Freiburg), Klaus H. Metzeler(University Hospital Leipzig), Michael D. Radmacher, Michael A. Caligiuri(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Maria R. Baer(University of Maryland, Baltimore), Guido Marcucci(City of Hope), Jonathan E. Kolitz(Memorial Sloan Kettering Cancer Center), Thomas H. Carter(University of Iowa), Richard A. Larson(Urbana University), Andrew J. Carroll(University of Alabama at Birmingham), Joseph O. Moore(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Krzysztof Mrózek(The Ohio State University), Dean Margeson(University of Iowa), Bayard L. Powell(Atrium Health Wake Forest Baptist), Susan P. Whitman(The Ohio State University Wexner Medical Center), Yue-Zhong Wu(University of Iowa), Kati Maharry(Peter MacCallum Cancer Centre)
Cited by 116
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k